Mood Disorders Research Program
The mission of the Mood Disorders Research Program is to expand our understanding of the causes of depression and bipolar disorder using the best available means of investigation. This is for the purpose of finding better ways of treating these complex conditions and developing early detection and intervention methods to prevent them.
Director: Richard Shelton, M.D.
Assistant: Waverly DeMers (e-mail)
Faculty/Clinicians
William Bobo
Virginia Gardner
Kirsten Haman
Steven Hollon
Brian Pollock
Jennifer Scroggie
Sandra Seidel
Staff
Stephanie Addington
Nicholas Bossaller
Bart Davis
Robert Hilton
Mac Kelly
Margaret Lovett
Tynya Patton
Rakesh Reddy
Brandy Sirles
Projects (Starred ones are recruiting)
1. A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder*
2. A Double-Blind, Placebo-Controlled study of Cariprazine (RGH-188) in Bipolar Depression*
3. A Phase II Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Safety, Tolerability and Efficacy of RG2417 (Uridine) in the Treatment of Bipolar I Depression*
4. The Psychiatric Genotype/Phenotype Project*
5. A Three-phase Study Designed to Test the Efficacy, Tolerability and Safety of the Combination of Ziprasidone with the Selective Serotonin Reuptake Inhibitor (SSRI) Escitalopram for Patients with Major Depressive Disorder (MDD) that do not Sufficiently Respond to Treatment with Escitalopram*
6. Double-Blind, Placebo Controlled Study of 6(S)-5-MTHF among SSRI-Resistant Outpatients with Major Depressive Disorder (MDD)*
7. Circadian Clock Gene Polymorphisms Associated with Depression
